US FDA’s Updated Clinical Trial Guidance Cuts Gender Language

 
• By Manas Mishra
  
Female and male sex symbols on pink and blue blocks
The US FDA removed gender-related language from reissued guidance on studying sex differences in clinical trials. (Chawalit Banpot/Shutterstock)

More from Diversity & Inclusion

More from Medtech Insight